An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy

An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy

Aino Fianu Jonasson,1 Mikael Åstrom2 1Department of Clinical Sciences, Intervention, and Technology, Division of Obstetrics and Gynaecology, Karolinska Institute, Stockholm, Sweden; 2StatCons, Malmö, SwedenCorrespondence: Aino Fianu JonassonDepartment of Clinical Science, Intervention and Technology...

Full description

Bibliographic Details
Main Authors: Jonasson AF, Åstrom M
Format: Article
Language:English
Published: Dove Medical Press 2021-06-01
Series:Medical Devices : Evidence and Research
Subjects:
vulvo vaginal atrophy
mbs
non-hormonal therapy
dyspareunia
vaginal dryness
adjuvant ai therapy
breast cancer
Online Access:https://www.dovepress.com/an-open-uncontrolled-pilot-study-on-12-week-use-of-vagivital-for-treat-peer-reviewed-fulltext-article-MDER

Internet

https://www.dovepress.com/an-open-uncontrolled-pilot-study-on-12-week-use-of-vagivital-for-treat-peer-reviewed-fulltext-article-MDER

Similar Items